Maziar Mike Doustdar

Two billion people worldwide are living with obesity, overweight or diabetes. At Novo Nordisk, we're dedicated to changing that reality. As CEO, I work alongside many passionate colleagues with one shared mission: driving change to defeat serious chronic diseases. To do this, we need to ensure fewer people develop metabolic and cardiovascular diseases, enable earlier diagnosis for those who do, and provide everyone with the treatment they need to live without limitations. Novo Nordisk has spent over 100 years leading the fight against serious chronic diseases. This heritage has given us the experience and capabilities to innovate globally while keeping patients at the heart of everything we do. +++ I welcome comments and questions. However, due to the nature of our industry and regulations, any comment that references a product or molecule will need to be removed. You can read our social media community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html If you have questions for my colleagues locally, you can find contact information for all our offices here: https://www.novonordisk.com/contact-us/find-local-information.html